Yamamoto H, Miyashita Y, Minamiguchi H, Hosomichi K, Yoshida S, Kioka H
Sci Rep. 2023; 13(1):19767.
PMID: 37957180
PMC: 10643531.
DOI: 10.1038/s41598-023-46915-1.
Greenshields-Watson A, Attaf M, MacLachlan B, Whalley T, Rius C, Wall A
Cell Rep. 2020; 32(2):107885.
PMID: 32668259
PMC: 7370177.
DOI: 10.1016/j.celrep.2020.107885.
Tian Y, Da Silva Antunes R, Sidney J, Arlehamn C, Grifoni A, Dhanda S
Front Immunol. 2018; 9:2778.
PMID: 30555469
PMC: 6281829.
DOI: 10.3389/fimmu.2018.02778.
Schultz H, Ostergaard S, Sidney J, Lamberth K, Sette A
PLoS One. 2018; 13(5):e0197407.
PMID: 29758051
PMC: 5951580.
DOI: 10.1371/journal.pone.0197407.
Dhanda S, Grifoni A, Pham J, Vaughan K, Sidney J, Peters B
Immunology. 2017; 153(1):118-132.
PMID: 28833085
PMC: 5721253.
DOI: 10.1111/imm.12816.
Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining.
Uchtenhagen H, Rims C, Blahnik G, Chow I, Kwok W, Buckner J
Nat Commun. 2016; 7:12614.
PMID: 27571776
PMC: 5013714.
DOI: 10.1038/ncomms12614.
A population response analysis approach to assign class II HLA-epitope restrictions.
Paul S, Dillon M, Arlehamn C, Huang H, Davis M, McKinney D
J Immunol. 2015; 194(12):6164-6176.
PMID: 25948811
PMC: 4458389.
DOI: 10.4049/jimmunol.1403074.
Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B.
Doganay L, Fejzullahu A, Katrinli S, Enc F, Ozturk O, Colak Y
World J Gastroenterol. 2014; 20(25):8179-86.
PMID: 25009391
PMC: 4081690.
DOI: 10.3748/wjg.v20.i25.8179.
A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
McKinney D, Southwood S, Hinz D, Oseroff C, Arlehamn C, Schulten V
Immunogenetics. 2013; 65(5):357-70.
PMID: 23392739
PMC: 3633633.
DOI: 10.1007/s00251-013-0684-y.
Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers.
Holland C, Rizkallah P, Vollers S, Calvo-Calle J, Madura F, Fuller A
Sci Rep. 2012; 2:629.
PMID: 22953050
PMC: 3432979.
DOI: 10.1038/srep00629.
Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M
BMC Bioinformatics. 2010; 11:568.
PMID: 21092157
PMC: 2998531.
DOI: 10.1186/1471-2105-11-568.
A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.
Zavala-Ruiz Z, Strug I, Walker B, Norris P, Stern L
Proc Natl Acad Sci U S A. 2004; 101(36):13279-84.
PMID: 15331779
PMC: 516560.
DOI: 10.1073/pnas.0403371101.
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
Fridkis-Hareli M, Santambrogio L, Stern J, Fugger L, Brosnan C, Strominger J
J Clin Invest. 2002; 109(12):1635-43.
PMID: 12070311
PMC: 151016.
DOI: 10.1172/JCI15402.
Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and....
Hennecke J, Wiley D
J Exp Med. 2002; 195(5):571-81.
PMID: 11877480
PMC: 2193773.
DOI: 10.1084/jem.20011194.
Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
Dzuris J, Sidney J, Horton H, Correa R, Carter D, Chesnut R
J Virol. 2001; 75(22):10958-68.
PMID: 11602736
PMC: 114676.
DOI: 10.1128/JVI.75.22.10958-10968.2001.
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.
Guilherme L, Oshiro S, Fae K, Cunha-Neto E, Renesto G, Goldberg A
Infect Immun. 2001; 69(9):5345-51.
PMID: 11500404
PMC: 98644.
DOI: 10.1128/IAI.69.9.5345-5351.2001.
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.
Hennecke J, Carfi A, Wiley D
EMBO J. 2000; 19(21):5611-24.
PMID: 11060013
PMC: 305780.
DOI: 10.1093/emboj/19.21.5611.
MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.
NOVAK E, Liu A, Nepom G, Kwok W
J Clin Invest. 1999; 104(12):R63-7.
PMID: 10606632
PMC: 480919.
DOI: 10.1172/JCI8476.
HLA-DRB1 leprogenic motifs in nigerian population groups.
Uko G, Lu L, Asuquo M, Fici D, Mahan S, Awdeh Z
Clin Exp Immunol. 1999; 118(1):56-62.
PMID: 10540160
PMC: 1905405.
DOI: 10.1046/j.1365-2249.1999.01034.x.
A mutational analysis of the Abetaz/Aalphad major histocompatibility complex class II molecule that restricts autoreactive T cells in (NZBxNZW)F1 mice. The critical influence of alanine at position 69 in the Aalphad chain.
Sai T, Mine M, Fukuoka M, Koarada S, Kimoto M
Immunology. 1999; 96(3):325-32.
PMID: 10233712
PMC: 2326757.
DOI: 10.1046/j.1365-2567.1999.00706.x.